Skip to main content
Clinical Trials/NCT04688957
NCT04688957
Unknown
Not Applicable

Osseodensification by Densah Burs Versus Osteotome for Transcrestal Maxillary Sinus Lifting With Simultaneous Implant Placement (Randomized Clinical Trial)

Hams Hamed Abdelrahman1 site in 1 country12 target enrollmentDecember 12, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Maxillary Sinus Lift
Sponsor
Hams Hamed Abdelrahman
Enrollment
12
Locations
1
Primary Endpoint
implant stability
Last Updated
5 years ago

Overview

Brief Summary

implant placement in the posterior maxilla is problematic, not only due to inferior properties of bone but also due to loss of vertical bone height which happens after extraction of posterior teeth. when the required additional height is few millimeters, indirect transcresta sinus lifting procedures are recommended.

This study compares sinus lifting using the conventional osteotome versus the osseodensification with densah burs.

Detailed Description

a total of 12 patients with missing maxillary premolars or molars and with limited vertical bone height below the maxillary sinus floor will receive implants either with osteotome or with Densah burs transcrestal sinus lifting to compare clinically and radiographically transcrestal sinus lifting with Densah burs and osteotome with simultaneous implant placement

Registry
clinicaltrials.gov
Start Date
December 12, 2020
End Date
August 1, 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Hams Hamed Abdelrahman
Responsible Party
Sponsor Investigator
Principal Investigator

Hams Hamed Abdelrahman

Assistant lecturer of DPH and Clinical statistician

Alexandria University

Eligibility Criteria

Inclusion Criteria

  • Patient with missing maxillary premolas and molars
  • Vertical bone height of 5-8 mm
  • Non smokers
  • Good oral hygiene

Exclusion Criteria

  • Bad oral hygiene
  • maxillary sinusitis
  • Presence of infection or periapical lesions in adjacent teeth
  • Bruxism or clenching
  • Alcoholism
  • Medically compromised patients with a condition that affect the procedure
  • Multiple sinus septa

Outcomes

Primary Outcomes

implant stability

Time Frame: at 6 months

Using the Osstell, The result is presented as an ISQ value of 1-100. The higher the ISQ, the more stable the implant

change in bone height

Time Frame: at baseline and 6 months

using CBCT

change in bone density

Time Frame: at baseline and 6 months

using CBCT

Secondary Outcomes

  • edema scores(at 2 weeks)
  • Pain scores(at 2 weeks)

Study Sites (1)

Loading locations...

Similar Trials